# Natalie Gauld

Natalie Joan Gauld ONZM is a New Zealand pharmacist, lecturer and researcher. She was appointed an Officer of the New Zealand Order of Merit for services to pharmacy and health in 2023.

## Academic career

Gauld grew up in Taranaki, and studied pharmacy at the Central Institute of Technology (now the Wellington Institute of Technology). Gauld completed a Master of Pharmacy degree at the University of Otago and a PhD titled How and why do developed countries vary in reclassifying medicines from prescription to non-prescription? at the University of Auckland. Gauld is a senior clinical lecturer at the university, and an honorary senior research fellow in the Faculty of Medical and Health Sciences. In March 2022 Gauld was diagnosed with motor neurone disease. At the end of 2023 she was appointed Research Advisor and Best Practice Advocate for the charity Motor Neurone Disease New Zealand.
Gauld has been a principal investigator in several research studies, including research on pharmacy services such as hepatitis C screening and vaccination in pregnancy. Gauld applied to the Medicines Classification Committee to reclassify some medicines, allowing them to be dispensed by pharmacists without prescription. The medications covered included vaccinations, melatonin used for insomnia, some oral contraceptives, and treatments for acne and psoriasis. She has also developed education and screening tools for pharmacists to assist with dispensing reclassified medicines.

## Honours and awards

In 2023 Gauld was appointed an Officer of the New Zealand Order of Merit for services to pharmacy and health. She was also awarded the 2022 Pharmaceutical Society of New Zealand Gold Award. She was elected a Fellow of the Pharmaceutical Society of New Zealand. Gauld won the Supreme Award in the 2018 Pharmacy Awards.

## Selected works

* Gauld, Natalie (14 June 2023). "Living with motor neurone disease". Pharmacy Today. Retrieved 17 July 2024.
* Natalie Gauld; Fiona Kelly; Nahoko Kurosawa; Linda J M Bryant; Lynne M Emmerton; Stephen Buetow (24 September 2014). "Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison". PLOS One. 9 (9): e107726. Bibcode:2014PLoSO...9j7726G. doi:10.1371/JOURNAL.PONE.0107726. ISSN 1932-6203. PMC 4175460. PMID 25251434. Wikidata Q34245674.
* Natalie Gauld; Fiona Kelly; John Shaw (3 November 2010). "Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand". Journal of Antimicrobial Chemotherapy. 66 (1): 201–204. doi:10.1093/JAC/DKQ409. ISSN 0305-7453. PMID 21051373. Wikidata Q43722275.
* Natalie J Gauld; Lance C Jennings; Chris Frampton; Q Sue Huang (4 September 2012). "Five years of non-prescription oseltamivir: effects on resistance, immunization and stockpiling". Journal of Antimicrobial Chemotherapy. 67 (12): 2949–2956. doi:10.1093/JAC/DKS337. ISSN 0305-7453. PMC 7314044. PMID 22949624. Wikidata Q30420974.
* Natalie Gauld; Fiona Kelly; Lynne M Emmerton; Stephen Buetow (18 March 2015). "Widening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand". PLOS One. 10 (3): e0119011. Bibcode:2015PLoSO..1019011G. doi:10.1371/JOURNAL.PONE.0119011. ISSN 1932-6203. PMC 4364766. PMID 25785589. Wikidata Q35191920.
* Natalie Gauld; Crystal S Braganza; Ola O Babalola; Tung T Huynh; Sarah M Hook (1 December 2016). "Reasons for use and non-use of the pertussis vaccine during pregnancy: an interview study". Journal of Primary Health Care. 8 (4): 344–350. doi:10.1071/HC15049. ISSN 1172-6156. PMID 29530159. Wikidata Q53656911.